图源startupticker 动物源性肉类和乳制品产生了全球20%以上的温室气体，占用了全球30%以上的水资源及70%以上的农 田资源。采用发酵衍生的蛋白质是更好的替代方案，其所需的水源和土地资源更少，且产生的温室气体 排放量低；同时，发酵蛋白质具有产品多样性，有望基于当地原料实现多种蛋白质的规模化生产。然 而，工业规模的设施和产能匮乏是当前生物质发酵发展的主要瓶颈。 图源startupticker 钛媒体APP注：自2011年以来，瑞士连续14年全球创新指数排名第一，是全球重要的创新策 源地，也是中国首个创新战略伙伴关系国，在创新发展和科技金融领域与中国具有极佳互补 性。 由Venturelab主办的"瑞士创新100强"，汇聚了最佳"瑞士制造"的初创及成长期科技创新 企业，是瑞士最具国际影响力的创新生态标杆。自2011年以来，该榜单每年在瑞士全国范围 内评选出100家最具开创性和市场前景的瑞士创新企业和25家最具独角兽潜力的瑞士成长期 企业，覆盖生命科学、工程机械、机器人、信息通信、低碳科技、食品科技等领域。 为了 全方位展示和介绍瑞士最前沿的创新科技，钛媒体APP与Venturelab的中国授权合作方以 ...

图源startupticker 动物源性肉类和乳制品产生了全球20%以上的温室气体，占用了全球30%以上的水资源及70%以上的农田资源。采用发酵衍生的蛋白质是更好的替代方案， 其所需的水源和土地资源更少，且产生的温室气体排放量低；同时，发酵蛋白质具有产品多样性，有望基于当地原料实现多种蛋白质的规模化生产。然而， 工业规模的设施和产能匮乏是当前生物质发酵发展的主要瓶颈。 图源startupticker 瑞士食品科技公司Planetary成立于2021年，公司致力于研发菌丝蛋白发酵技术，可为微生物精准生产和菌丝生物质发酵企业提供工业级规模化生物质发酵产 能支持，以及菌丝蛋白原料产品。 Planetary由Marison Ian与David Brandes共同创立。Marison Ian为公司首席科学官，在工业发酵领域拥有 40 多年的学术和工业经验。David Brandes为公司执行 官，为Peace of Meat联合创始人与联合首席执行官。 Planetary为生物质发酵和精密发酵领域头部企业提供工业规模的上游和下游制造服务，同时以B2B原料形式销售菌丝蛋白，用于肉类和乳制品替代品的生 产，有效解决了发酵行 ...

Core Insights - The company has established a pilot production line for mycelium protein and completed the research on the pilot production process, indicating a foundation for industrialization and promotion [1] - A new production facility is currently under construction, which is expected to enhance production capacity [1] - According to the feasibility study report, once the project is fully operational, it is projected to generate an annual revenue of 1.3 billion yuan [1]

Core Insights - The Chinese biological manufacturing industry is experiencing robust growth, with a total scale nearing 1 trillion yuan and fermentation capacity accounting for over 70% of the global market [1][2] - Microbial protein represents a disruptive innovation in the food supply system, offering a more efficient and environmentally friendly alternative to traditional agriculture and livestock farming [3][4] Industry Overview - The biological manufacturing sector is characterized by the use of industrial biotechnology, leveraging microorganisms, cells, and enzymes for product production [2] - The industry is currently in a "blue ocean" phase, with less than 1% of microbial species on Earth having been discovered, indicating significant potential for resource exploration and development [2] Technological Advancements - New strains of fungi developed through large-scale industrial fermentation can yield protein content exceeding 50%, comparable to animal-derived meat in terms of nutrition and taste [1] - Synthetic biology techniques are significantly reducing the costs of pharmaceuticals, such as the production of bear bile acid substitutes, which are now much more affordable and environmentally sustainable [4][5] Environmental Impact - Microbial protein production can replace the protein generated from traditional sources like soybeans and livestock, leading to a reduction of over 90% in land, water usage, and carbon emissions [3] - The production facility for fungal protein can replace the protein output of 10,000 cattle or 24 million chickens, showcasing its environmental advantages [3] Policy and Investment - The growth of the biological manufacturing industry is supported by targeted industrial policies and patient capital, which are crucial for scaling production and fostering innovation [5][6] - The Ministry of Industry and Information Technology (MIIT) is actively promoting the application of artificial intelligence in biological manufacturing and facilitating the transition from research to industrial application [7] Collaboration and Innovation - Successful innovation in the biological manufacturing sector requires collaboration between academia and industry, with a focus on integrating research outcomes into practical applications [6][7] - The establishment of innovation centers aims to bridge the gap between basic research and industrial implementation, facilitating the transfer of scientific achievements into market-ready products [7]

【SynBioCon】 获 悉， 4月28日，主题为"技术造物 创引未来"的天津港保税区生物制造产业新闻发 布会举行。会上，天津港保税区发布了 《天津港保税区推动生物制造产业高质量发展行动方案》 （以 下简称《行动方案》）和 《天津港保税区关于支持生物制造产业高质量发展的若干政策》 （以下简 称"生物制造十条"）。 近些年，生物制造作为全新的"造物"技术，成为全球竞相布局的科技战略高地。今年政府工作报告中 提到，因地制宜发展新质生产力，培育生物制造、量子科技、具身智能、6G等未来产业。我市去年已 印发《天津市加快合成生物创新策源推动生物制造产业高质量发展实施方案》，天津港保税区按照全市 工作部署正全力打造生物制造先导区。此次发布会展现了天津港保税区生物制造产业在创新策源、成果 产业化、空间布局、人才支撑、标志性项目等方面的先发优势及推动生物制造创新成果产业化应用实 践，促进新产业、新模式、新动能加快 落地。 01 政策上新 全力打造百亿级产业集群 记者从会上获悉，《行动方案》以推动生物制造创新成果产业化应用实践为主线，因地制宜构建符合新 质生产力发展的新型生产关系，重点聚焦创新策源地、孵化转化高地和创新生态三 ...